FREE SHIPPING on orders over $300 | ≥99% Purity Guaranteed
Back to Shop

Product Information

Tesamorelin GHRH Analog
Intermediate
Stimulates growth hormone release to reduce visceral adipose tissue
FDA-approved for reducing visceral adiposity in HIV-associated lipodystrophyInvestigated for potential metabolic and anti-aging applicationsStimulates GH/IGF-1 releaseSupports body composition improvements
Visceral fat reductionBody compositionMetabolic health
1-2mg
Once daily
Typically in the evening before bed. Same dosing whether clinical use (lipodystrophy) or off-label (anti-aging/metabolic).
3-6 months
Clinical protocols: 6 months or longer continuous use. Off-label wellness: often 3-6 months, sometimes extended if tolerated.
1-2 months
Not strictly defined in clinical trials (some stay on chronically). Off-label use: 1-2 month break after 3-6 months. Some rotate quarterly: 3 months on, 1 month off.
FDA-approved for reducing visceral adiposity in HIV-associated lipodystrophyInvestigated for potential metabolic and anti-aging applicationsStimulates GH/IGF-1 releaseSupports body composition improvements
No supervision required
FDA-approved for visceral fat reduction in HIV lipodystrophy (Egrifta)
  • ⚠️ Active cancer
  • ⚠️ Pregnancy
  • ⚠️ Breastfeeding
  • ⚠️ Pituitary disorders
Monitor visceral fatTrack IGF-1 levelsWatch for injection site reactions
  • 🔬 IGF-1
None
IGF-1 monitoring recommended for long-term use. Specifically targets visceral fat.

Product Details

GHRH Analog

What is Tesamorelin?

Tesamorelin is a synthetic peptide medication used for specific medical purposes. It is designed to stimulate the production of growth hormone-releasing hormone (GHRH) in the body.

How does Tesamorelin work in the body?

Tesamorelin works by enhancing the secretion of growth hormone (GH) from the pituitary gland. It does this by mimicking the action of natural GHRH, which stimulates the release of GH.

Primary Benefits:

  • Improved Fat Metabolism & Body Composition: Reduces visceral adipose tissue (VAT)
  • Enhanced Cognitive Function: May have neuroprotective effects and improve cognitive function
  • Support for Skin & Muscle Health: Promotes synthesis of growth hormone for healthier skin and muscle
  • Reduces visceral fat specifically
  • Improves lipid profiles
  • Enhanced body composition

The Science Behind Tesamorelin

The science behind Tesamorelin lies in its ability to modulate the production of growth hormone in the body. At its core, Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH), a naturally occurring peptide that stimulates the pituitary gland to release growth hormone (GH). By mimicking GHRH, Tesamorelin effectively amplifies the body's own GH secretion, which plays a pivotal role in various physiological processes, including growth, metabolism, and tissue repair. This mechanism of action is particularly relevant in the context of HIV-associated lipodystrophy, where Tesamorelin's ability to promote the redistribution of body fat and improve metabolic parameters has been clinically demonstrated. Best for: Individuals focused on fat loss and metabolic health improvement.

Frequently Asked Questions

Are there any potential side effects associated with Tesamorelin?

Common side effects of Tesamorelin may include joint pain, injection site reactions, and muscle pain. It's important to discuss potential side effects with a healthcare provider.

How is Tesamorelin administered to patients?

Tesamorelin is typically administered by subcutaneous injection, usually on a daily basis, as directed by a healthcare professional.

What is the typical treatment duration for Tesamorelin therapy?

The treatment duration with Tesamorelin can vary depending on individual patient needs and the condition being treated. It is typically used for several months to achieve desired outcomes.

What ongoing research or developments are there in the field of Tesamorelin therapy?

Ongoing research is exploring potential new applications for Tesamorelin in areas such as muscle wasting disorders and metabolic conditions. Keep an eye on emerging studies and clinical trials for the latest developments.
21+

Confirm your age

Please verify that you are 21 years of age or older to access this website: